Trial Outcomes & Findings for Priming Expectations and Motor Learning With tDCS (NCT NCT06039605)
NCT ID: NCT06039605
Last Updated: 2026-07-31
Results Overview
This will be calculated as the average of two trials of the motor task that are completed one week after the last training session. The motor task is a timed test that requires participants to spoon two beans (kidney, raw) at a time from a center proximal "start" cup to three distal "target" cups as fast as possible. In short, this task requires multijoint coordination and limb reversal, and performance for each trial is measured in seconds.
COMPLETED
NA
140 participants
One-Week Follow-Up visit (Day 10)
2026-07-31
Participant Flow
Participant milestones
| Measure |
Control
This group will only receive motor training, which consists of 10 trials of motor training per day across 3 days, followed by a one-week follow-up of 2 trials.
|
tDCS1
This group will receive motor training concurrent with 20 minutes of either sham or active tDCS. Sham tDCS will be a 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. The next 18 minutes will have no stimulation (0 mA), starting at minute 19 with 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. Active tDCS will ramp up to 2 mA in the first 30 seconds, then stay at 2 mA for 19 minutes, then ramp down to 0 mA.
|
tDCS2
This group will first read some information about tDCS based on cited studies. They will then receive the same motor training and tDCS as the tDCS1 arm.
|
tDCS3
This group will first read some information about tDCS based on cited studies, but different cited studies than the tDCS2 arm. They will then receive the same motor training and tDCS as the tDCS1 and 2 arms.
|
|---|---|---|---|---|
|
Overall Study
STARTED
|
25
|
38
|
38
|
39
|
|
Overall Study
COMPLETED
|
25
|
38
|
38
|
39
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Priming Expectations and Motor Learning With tDCS
Baseline characteristics by cohort
| Measure |
Control
n=25 Participants
This group will only receive motor training, which consists of 10 trials of motor training per day across 3 days, followed by a one-week follow-up of 2 trials.
|
tDCS1
n=37 Participants
This group will receive motor training concurrent with 20 minutes of either sham or active tDCS. Sham tDCS will be a 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. The next 18 minutes will have no stimulation (0 mA), starting at minute 19 with 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. Active tDCS will ramp up to 2 mA in the first 30 seconds, then stay at 2 mA for 19 minutes, then ramp down to 0 mA.
|
tDCS2
n=37 Participants
This group will first read some information about tDCS based on cited studies. They will then receive the same motor training and tDCS as the tDCS1 arm.
|
tDCS3
n=39 Participants
This group will first read some information about tDCS based on cited studies, but different cited studies than the tDCS2 arm. They will then receive the same motor training and tDCS as the tDCS1 and 2 arms.
|
Total
n=138 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|
|
Age, Continuous
|
23.36 years
STANDARD_DEVIATION 11.34 • n=9 Participants
|
22.27 years
STANDARD_DEVIATION 3.73 • n=27 Participants
|
22.97 years
STANDARD_DEVIATION 7.40 • n=267 Participants
|
21.59 years
STANDARD_DEVIATION 3.38 • n=265 Participants
|
22.46 years
STANDARD_DEVIATION 6.65 • n=568 Participants
|
|
Sex: Female, Male
Female
|
13 Participants
n=9 Participants
|
15 Participants
n=27 Participants
|
17 Participants
n=267 Participants
|
19 Participants
n=265 Participants
|
64 Participants
n=568 Participants
|
|
Sex: Female, Male
Male
|
12 Participants
n=9 Participants
|
22 Participants
n=27 Participants
|
20 Participants
n=267 Participants
|
20 Participants
n=265 Participants
|
74 Participants
n=568 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=9 Participants
|
0 Participants
n=27 Participants
|
0 Participants
n=267 Participants
|
0 Participants
n=265 Participants
|
0 Participants
n=568 Participants
|
|
Race (NIH/OMB)
Asian
|
13 Participants
n=9 Participants
|
24 Participants
n=27 Participants
|
24 Participants
n=267 Participants
|
21 Participants
n=265 Participants
|
82 Participants
n=568 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=9 Participants
|
0 Participants
n=27 Participants
|
0 Participants
n=267 Participants
|
0 Participants
n=265 Participants
|
0 Participants
n=568 Participants
|
|
Race (NIH/OMB)
Black or African American
|
2 Participants
n=9 Participants
|
0 Participants
n=27 Participants
|
0 Participants
n=267 Participants
|
3 Participants
n=265 Participants
|
5 Participants
n=568 Participants
|
|
Race (NIH/OMB)
White
|
8 Participants
n=9 Participants
|
11 Participants
n=27 Participants
|
9 Participants
n=267 Participants
|
11 Participants
n=265 Participants
|
39 Participants
n=568 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=9 Participants
|
2 Participants
n=27 Participants
|
2 Participants
n=267 Participants
|
3 Participants
n=265 Participants
|
7 Participants
n=568 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
2 Participants
n=9 Participants
|
0 Participants
n=27 Participants
|
2 Participants
n=267 Participants
|
1 Participants
n=265 Participants
|
5 Participants
n=568 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
5 Participants
n=9 Participants
|
4 Participants
n=27 Participants
|
7 Participants
n=267 Participants
|
3 Participants
n=265 Participants
|
19 Participants
n=568 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
20 Participants
n=9 Participants
|
33 Participants
n=27 Participants
|
30 Participants
n=267 Participants
|
36 Participants
n=265 Participants
|
119 Participants
n=568 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=9 Participants
|
0 Participants
n=27 Participants
|
0 Participants
n=267 Participants
|
0 Participants
n=265 Participants
|
0 Participants
n=568 Participants
|
|
Region of Enrollment
United States
|
25 Participants
n=9 Participants
|
37 Participants
n=27 Participants
|
37 Participants
n=267 Participants
|
39 Participants
n=265 Participants
|
138 Participants
n=568 Participants
|
PRIMARY outcome
Timeframe: One-Week Follow-Up visit (Day 10)Population: All subjects who were randomized, completed the study and had no missing Day 1 expectancy data.
This will be calculated as the average of two trials of the motor task that are completed one week after the last training session. The motor task is a timed test that requires participants to spoon two beans (kidney, raw) at a time from a center proximal "start" cup to three distal "target" cups as fast as possible. In short, this task requires multijoint coordination and limb reversal, and performance for each trial is measured in seconds.
Outcome measures
| Measure |
tDCS1
n=37 Participants
This group will receive motor training concurrent with 20 minutes of either sham or active tDCS. Sham tDCS will be a 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. The next 18 minutes will have no stimulation (0 mA), starting at minute 19 with 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. Active tDCS will ramp up to 2 mA in the first 30 seconds, then stay at 2 mA for 19 minutes, then ramp down to 0 mA.
|
tDCS2
n=37 Participants
This group will first read some information about tDCS based on cited studies. They will then receive the same motor training and tDCS as the tDCS1 arm.
|
tDCS3
n=39 Participants
This group will first read some information about tDCS based on cited studies, but different cited studies than the tDCS2 arm. They will then receive the same motor training and tDCS as the tDCS1 and 2 arms.
|
Control
n=25 Participants
This group will only receive motor training, which consists of 10 trials of motor training per day across 3 days, followed by a one-week follow-up of 2 trials.
|
|---|---|---|---|---|
|
Performance on Motor Task One Week After Final Training Session
|
48.02 time in seconds
Standard Deviation 5.61
|
47.14 time in seconds
Standard Deviation 6.86
|
47.23 time in seconds
Standard Deviation 7.09
|
48.50 time in seconds
Standard Deviation 7.02
|
SECONDARY outcome
Timeframe: Day 1, 2, and 3Population: All subjects who were randomized, completed the study and had no missing Day 1 expectancy data.
This outcome measure will be measured as the slope of the line fitted to the motor task performance across all 30 training trials (this includes Day 1, 2 and 3), when trial is transformed to a logarithmic scale. This transformation is done to account for the fact that change in performance is non-linear. The motor task is a timed test that requires participants to spoon two beans (kidney, raw) at a time from a center proximal "start" cup to three distal "target" cups as fast as possible. In short, this task requires multijoint coordination and limb reversal, and performance for each trial is measured in seconds.
Outcome measures
| Measure |
tDCS1
n=37 Participants
This group will receive motor training concurrent with 20 minutes of either sham or active tDCS. Sham tDCS will be a 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. The next 18 minutes will have no stimulation (0 mA), starting at minute 19 with 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. Active tDCS will ramp up to 2 mA in the first 30 seconds, then stay at 2 mA for 19 minutes, then ramp down to 0 mA.
|
tDCS2
n=37 Participants
This group will first read some information about tDCS based on cited studies. They will then receive the same motor training and tDCS as the tDCS1 arm.
|
tDCS3
n=39 Participants
This group will first read some information about tDCS based on cited studies, but different cited studies than the tDCS2 arm. They will then receive the same motor training and tDCS as the tDCS1 and 2 arms.
|
Control
n=25 Participants
This group will only receive motor training, which consists of 10 trials of motor training per day across 3 days, followed by a one-week follow-up of 2 trials.
|
|---|---|---|---|---|
|
Change in Motor Performance Over the Course of Training
|
-0.09 Log(seconds) per trial
Standard Deviation 2.14
|
0.04 Log(seconds) per trial
Standard Deviation 2.01
|
-0.24 Log(seconds) per trial
Standard Deviation 2.46
|
0.45 Log(seconds) per trial
Standard Deviation 2.60
|
SECONDARY outcome
Timeframe: Day 1 and Follow-Up (Day 10)Population: All subjects who belong to the tDCS groups, were randomized, completed the study and had no missing data for both Day 1 and Follow-Up expectancy data
This will be the change (Day 1 minus Day 10) in expectations of tDCS. The tDCS expectation scores are taken from a 1-item survey adapted from the Expectation Assessment Scale, where scores range from 0 (no expectation) to 8 (high expectations); a score of 4 is considered neutral.
Outcome measures
| Measure |
tDCS1
n=36 Participants
This group will receive motor training concurrent with 20 minutes of either sham or active tDCS. Sham tDCS will be a 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. The next 18 minutes will have no stimulation (0 mA), starting at minute 19 with 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. Active tDCS will ramp up to 2 mA in the first 30 seconds, then stay at 2 mA for 19 minutes, then ramp down to 0 mA.
|
tDCS2
n=39 Participants
This group will first read some information about tDCS based on cited studies. They will then receive the same motor training and tDCS as the tDCS1 arm.
|
tDCS3
This group will first read some information about tDCS based on cited studies, but different cited studies than the tDCS2 arm. They will then receive the same motor training and tDCS as the tDCS1 and 2 arms.
|
Control
n=37 Participants
This group will only receive motor training, which consists of 10 trials of motor training per day across 3 days, followed by a one-week follow-up of 2 trials.
|
|---|---|---|---|---|
|
Change in tDCS Expectations From Day 1 to Day 10
Change in tDCS Expectation
|
0.083 Score on a scale
Standard Deviation 1.54
|
-0.154 Score on a scale
Standard Deviation 1.40
|
—
|
0.108 Score on a scale
Standard Deviation 1.85
|
|
Change in tDCS Expectations From Day 1 to Day 10
Expectation at Baseline (Day 1)
|
4.50 Score on a scale
Standard Deviation 1.84
|
4.64 Score on a scale
Standard Deviation 1.56
|
—
|
5 Score on a scale
Standard Deviation 1.2
|
|
Change in tDCS Expectations From Day 1 to Day 10
Expectation at Follow-Up
|
4.41 Score on a scale
Standard Deviation 2.15
|
4.79 Score on a scale
Standard Deviation 1.79
|
—
|
4.89 Score on a scale
Standard Deviation 2.02
|
SECONDARY outcome
Timeframe: One-Week Follow-Up (Day 10)Population: All subjects who were randomized completed the study and had no missing Day 1 expectancy or kinematics data.
This is the average amount of time spent in the home cup for each repetition, averaged across the two follow-up trials.
Outcome measures
| Measure |
tDCS1
n=35 Participants
This group will receive motor training concurrent with 20 minutes of either sham or active tDCS. Sham tDCS will be a 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. The next 18 minutes will have no stimulation (0 mA), starting at minute 19 with 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. Active tDCS will ramp up to 2 mA in the first 30 seconds, then stay at 2 mA for 19 minutes, then ramp down to 0 mA.
|
tDCS2
n=37 Participants
This group will first read some information about tDCS based on cited studies. They will then receive the same motor training and tDCS as the tDCS1 arm.
|
tDCS3
n=37 Participants
This group will first read some information about tDCS based on cited studies, but different cited studies than the tDCS2 arm. They will then receive the same motor training and tDCS as the tDCS1 and 2 arms.
|
Control
n=23 Participants
This group will only receive motor training, which consists of 10 trials of motor training per day across 3 days, followed by a one-week follow-up of 2 trials.
|
|---|---|---|---|---|
|
Average Dwell Time
|
18.02 Time in seconds
Standard Deviation 4.85
|
17.90 Time in seconds
Standard Deviation 5.07
|
18.23 Time in seconds
Standard Deviation 5.04
|
18.39 Time in seconds
Standard Deviation 3.36
|
SECONDARY outcome
Timeframe: One-Week Follow-Up (Day 10)Population: All subjects who were randomized completed the study and had no missing Day 1 expectancy or kinematics data.
his is the average peak velocity for the outward portion of each repetition, averaged across the two follow-up trials.
Outcome measures
| Measure |
tDCS1
n=37 Participants
This group will receive motor training concurrent with 20 minutes of either sham or active tDCS. Sham tDCS will be a 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. The next 18 minutes will have no stimulation (0 mA), starting at minute 19 with 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. Active tDCS will ramp up to 2 mA in the first 30 seconds, then stay at 2 mA for 19 minutes, then ramp down to 0 mA.
|
tDCS2
n=34 Participants
This group will first read some information about tDCS based on cited studies. They will then receive the same motor training and tDCS as the tDCS1 arm.
|
tDCS3
n=37 Participants
This group will first read some information about tDCS based on cited studies, but different cited studies than the tDCS2 arm. They will then receive the same motor training and tDCS as the tDCS1 and 2 arms.
|
Control
n=23 Participants
This group will only receive motor training, which consists of 10 trials of motor training per day across 3 days, followed by a one-week follow-up of 2 trials.
|
|---|---|---|---|---|
|
Average Peak Reach Velocity
|
0.11 Velocity (m/s)
Standard Deviation 0.08
|
0.12 Velocity (m/s)
Standard Deviation 0.13
|
0.13 Velocity (m/s)
Standard Deviation 0.10
|
0.16 Velocity (m/s)
Standard Deviation 0.22
|
SECONDARY outcome
Timeframe: Days 1, 2, 3, and 10Population: All subjects who belong to the tDCS groups, were randomized, completed the study and had no missing expectancy data
This is the coefficient of variation (CV) for tDCS expectation scores. It is calculated by dividing the standard deviation of the participant's expectations across study days (Days 1, 2, 3, and 10) by the mean expectation of these 4 study days. The tDCS expectation scores are taken from a 1-item survey adapted from the Expectation Assessment Scale, where scores range from 0 (no expectation) to 8 (high expectations); a score of 4 is considered neutral.
Outcome measures
| Measure |
tDCS1
n=36 Participants
This group will receive motor training concurrent with 20 minutes of either sham or active tDCS. Sham tDCS will be a 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. The next 18 minutes will have no stimulation (0 mA), starting at minute 19 with 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. Active tDCS will ramp up to 2 mA in the first 30 seconds, then stay at 2 mA for 19 minutes, then ramp down to 0 mA.
|
tDCS2
n=39 Participants
This group will first read some information about tDCS based on cited studies. They will then receive the same motor training and tDCS as the tDCS1 arm.
|
tDCS3
This group will first read some information about tDCS based on cited studies, but different cited studies than the tDCS2 arm. They will then receive the same motor training and tDCS as the tDCS1 and 2 arms.
|
Control
n=37 Participants
This group will only receive motor training, which consists of 10 trials of motor training per day across 3 days, followed by a one-week follow-up of 2 trials.
|
|---|---|---|---|---|
|
Variability in Transcranial Direct Current Stimulation Expectations
|
0.238 Ratio (for CV)
Standard Deviation 0.28
|
0.179 Ratio (for CV)
Standard Deviation 0.16
|
—
|
0.183 Ratio (for CV)
Standard Deviation 0.17
|
SECONDARY outcome
Timeframe: Days 1, 2, and 3Population: All subjects who belong to the tDCS groups, were randomized, completed the study and had no missing Day 1 expectancy data
This is calculated using a 14-item self-rated questionnaire, with answers for each item ranging from 1 ("absent") to 10 ("severe"). A daily average score (ranging from 1 to 10) was calculated for each participant by averaging the 14 items. The reported values represent the mean of these daily averages per group. Higher values represent more severe symptoms (a worse outcome).
Outcome measures
| Measure |
tDCS1
n=37 Participants
This group will receive motor training concurrent with 20 minutes of either sham or active tDCS. Sham tDCS will be a 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. The next 18 minutes will have no stimulation (0 mA), starting at minute 19 with 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. Active tDCS will ramp up to 2 mA in the first 30 seconds, then stay at 2 mA for 19 minutes, then ramp down to 0 mA.
|
tDCS2
n=39 Participants
This group will first read some information about tDCS based on cited studies. They will then receive the same motor training and tDCS as the tDCS1 arm.
|
tDCS3
This group will first read some information about tDCS based on cited studies, but different cited studies than the tDCS2 arm. They will then receive the same motor training and tDCS as the tDCS1 and 2 arms.
|
Control
n=37 Participants
This group will only receive motor training, which consists of 10 trials of motor training per day across 3 days, followed by a one-week follow-up of 2 trials.
|
|---|---|---|---|---|
|
Post-tDCS Symptom Questionnaire Score
Average of 14 Post-tDCS symptoms on Day 1
|
1.19 Score on a scale
Interval 1.0 to 3.0
|
1.24 Score on a scale
Interval 1.0 to 2.0
|
—
|
1.20 Score on a scale
Interval 1.0 to 2.0
|
|
Post-tDCS Symptom Questionnaire Score
Average of 14 Post-tDCS symptoms on Day 2
|
1.13 Score on a scale
Interval 1.0 to 2.0
|
1.13 Score on a scale
Interval 1.0 to 2.0
|
—
|
1.15 Score on a scale
Interval 1.0 to 2.0
|
|
Post-tDCS Symptom Questionnaire Score
Average of 14 Post-tDCS symptoms on Day 3
|
1.10 Score on a scale
Interval 1.0 to 2.0
|
1.10 Score on a scale
Interval 1.0 to 2.0
|
—
|
1.12 Score on a scale
Interval 1.0 to 2.0
|
SECONDARY outcome
Timeframe: Days 1, 2, 3, and 10Population: All subjects who belong to the tDCS groups, were randomized, completed the study and had no missing expectancy data
The tDCS expectation scores are taken from a 1-item survey adapted from the Expectation Assessment Scale, where scores range from 0 (no expectation) to 8 (high expectations); a score of 4 is considered neutral. This score was collected for each participant in the experimental group (tDCS1, tDCS2, tDCS3) across study days (Days 1, 2, 3, and 10).
Outcome measures
| Measure |
tDCS1
n=36 Participants
This group will receive motor training concurrent with 20 minutes of either sham or active tDCS. Sham tDCS will be a 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. The next 18 minutes will have no stimulation (0 mA), starting at minute 19 with 30-second ramp up from 0 to 2 milliamps (MA), then a 30-second ramp-down from 2 mA to 0 mA. Active tDCS will ramp up to 2 mA in the first 30 seconds, then stay at 2 mA for 19 minutes, then ramp down to 0 mA.
|
tDCS2
n=39 Participants
This group will first read some information about tDCS based on cited studies. They will then receive the same motor training and tDCS as the tDCS1 arm.
|
tDCS3
This group will first read some information about tDCS based on cited studies, but different cited studies than the tDCS2 arm. They will then receive the same motor training and tDCS as the tDCS1 and 2 arms.
|
Control
n=37 Participants
This group will only receive motor training, which consists of 10 trials of motor training per day across 3 days, followed by a one-week follow-up of 2 trials.
|
|---|---|---|---|---|
|
tDCS Expectation Scores
Expectation Score at Baseline (Day 1)
|
4.50 Scale scores (for Days)
Standard Deviation 1.84
|
4.64 Scale scores (for Days)
Standard Deviation 1.56
|
—
|
5.00 Scale scores (for Days)
Standard Deviation 1.2
|
|
tDCS Expectation Scores
Expectation Score at Day 2
|
5.02 Scale scores (for Days)
Standard Deviation 1.84
|
5.13 Scale scores (for Days)
Standard Deviation 1.78
|
—
|
5.35 Scale scores (for Days)
Standard Deviation 1.7
|
|
tDCS Expectation Scores
Expectation Score at Day 3
|
5.02 Scale scores (for Days)
Standard Deviation 1.92
|
5.20 Scale scores (for Days)
Standard Deviation 1.85
|
—
|
5.35 Scale scores (for Days)
Standard Deviation 1.82
|
|
tDCS Expectation Scores
Expectation Score at Follow-Up (Day 10)
|
4.41 Scale scores (for Days)
Standard Deviation 2.15
|
4.79 Scale scores (for Days)
Standard Deviation 1.79
|
—
|
4.89 Scale scores (for Days)
Standard Deviation 2.02
|
Adverse Events
tDCS3
Control
tDCS1
tDCS2
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place